July 3, 2026 · Gut · DOI: 10.1136/gutjnl-2025-337363

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment

Listen to this summary

The authors investigate the role of acid sphingomyelinase (SMPD1) in sphingolipid metabolism and its impact on pancreatic ductal adenocarcinoma (PDAC) progression. They find that SMPD1 expression is linked to poorer patient outcomes and that its ablation reduces tumor growth and metastasis by impairing Kras<sup>G12D</sup> signaling. This study suggests that targeting SMPD1 may offer a novel therapeutic strategy within the Kras signaling pathway for treating PDAC.

Ahmed Alnatsha, Jianying Xu, Tahib Habshi, Qi Li, Klea Rickú, Prince Allawadhi, Didem Saka, Ruoxan Dai, Yuxing Xue, Hang Nguyen, Helena Stadler, Theresa Weltermann, Quan Zhou, Nicole Schreiner, Yonggan Xue, Victoria Rittinghausen, Steffen Ormanns, Fredrick Klauschen, Danmei Zhang, Stefan Böck, Martin Benoit, Najib Ben Khaled, Shibojyoti Lahiri, Axel Imhof, Andreas Klingl, Anjali Jaiswal, Girija P Sahoo, Ivonne Regel, Sebastian Mueller, Rupert Öllinger, Roland Rad, Claus Belka, Tanja Bange, Kirsten Lauber, Julia Mayerle, Ujjwal M Mahajan

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play